|1.||Wang, Yu-Ping: 1 article (11/2007)|
|2.||Fu, Xin: 1 article (11/2007)|
|3.||Gamboa da Costa, Gonçalo: 1 article (11/2007)|
|4.||Doerge, Daniel R: 1 article (11/2007)|
|5.||Churchwell, Mona I: 1 article (11/2007)|
|6.||Marques, M Matilde: 1 article (11/2007)|
|7.||Beland, Frederick A: 1 article (11/2007)|
|8.||Gamboa da Costa, G: 1 article (08/2001)|
|9.||McDaniel-Hamilton, L P: 1 article (08/2001)|
|10.||Heflich, R H: 1 article (08/2001)|
08/01/2001 - "Since the contribution of these alpha-hydroxy metabolites of tamoxifen to the induction of endometrial tumors is presently unknown, we compared the extent of DNA adduct formation in liver and selected non-hepatic tissues of female Sprague-Dawley rats treated by gavage with tamoxifen, alpha-hydroxytamoxifen, N-desmethyltamoxifen, alpha-hydroxy-N-desmethyltamoxifen and N,N-didesmethyltamoxifen, or intraperitoneal injection with tamoxifen, alpha-hydroxytamoxifen, 3-hydroxytamoxifen and 4-hydroxytamoxifen. "
|2.||Body Weight (Weight, Body)
11/18/2007 - "To test this hypothesis directly, we compared the extent of tamoxifen-DNA adduct formation in rats co-administered 27micromol N,N-didesmethyltamoxifen per kg body weight and either 27micromol tamoxifen per kg body weight or 27micromol alpha-hydroxytamoxifen per kg body weight daily for 7days. "
|2.||DNA (Deoxyribonucleic Acid)